Cancer Genetics, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
The following report cites that the company requires the conduct of animal testing for FDA approval.
“The Investigational Device Exemption application must be supported by appropriate data, such as animal and laboratory testing results.” (Page 31) Read the full document.
Cancer Genetics, Inc. is an early-stage diagnostics company that engages in the development and commercializes proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. Its developments include DNA-FISH Probes, CGH Microarrays and next-generation sequencing treatments. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. [Source: MarketWatch]
Company Website: www.cancergenetics.com